Real-time enrollment status for this indolent systemic mastocytosis clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 11:15 PM UTC
| NCT Number | NCT07264959 |
| Recruiting Status | Recruiting |
| Condition | Indolent Systemic Mastocytosis |
| Phase | Clinical Trial |
| Target Enrollment | 150 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Blueprint Medicines Corporation |
| Last Updated on CT.gov | April 22, 2026 (Apr 22, 2026) |
As of July 17, 2026: Clinical trial NCT07264959 is currently recruiting participants. This clinical trial study for indolent systemic mastocytosis is actively seeking new participants at 1 location across the United States. The study is sponsored by Blueprint Medicines Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07264959 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07264959 was last updated Apr 22, 2026 (April 22, 2026). HelloStudys verifies this status automatically.